Watch the black rubber tip of the plunger, not the plunger handle
Transports long chain fatty acids to be used as energy PRODUCT DIRECTIONS / ADDITIONAL INFO As a dietary supplement, take one tablespoon daily
An oral formulation for both diabetes and obesity is in development for 2027, which matters because oral delivery is where the true mass market lies
however, the clinical relevance of incretin-related autoantibodies in the development of hyperglycemia remains unclear

Weight loss effectiveness Average weight loss expectations: 0.5mg daily: 8-10% over 24 weeks 1.0mg daily: 10-12% over 24 weeks Starting weight ~220 lbs: Lose 22-26 lbs Better than most weight loss medications Similar to GLP-1 agonists Individual variation: Timeline for weight loss: Week 1-2: 2-4 lbs (water weight + appetite suppression ) Week 3-4: 1-2 lbs/week (fat loss beginning) Month 2-3: 1-1.5 lbs/week (steady loss) Month 4-6: 0.5-1 lb/week (slowing, approaching plateau) Month 6-9: 0-0.5 lb/week (maintenance/plateau) Total: 20-30 lbs typical over 6 months Body composition changes: Primarily fat loss (75-80% of loss) Some muscle loss (20-25%) - unavoidable in deficit Better muscle preservation than pure caloric restriction Waist circumference reduction significant Visceral fat preferentially lost See peptides before and after results and how long peptides take to work

Rybelsus should be used with caution in patients with severe kidney dysfunction Semaglutide should not be used in individuals with a personal or family history of Medullary Thyroid Carcinoma (MTC) or in those with Multiple Endocrine Neoplasia syndrome type 2